December 2017 - Page 7 of 31

ThursdayDec 07, 2017 2:30 pm

VivoPower International PLC (NASDAQ: VVPR) Starts Presentation at LD Micro Main Event

VivoPower International PLC (NASDAQ: VVPR) engages in the provision of solar power generation services. Its business model encompasses power support services, rooftop CIG BTO and ground mount utility BTO sales, energy efficient and storage and smart green power services and technology and new energy investments. VivoPower’s business model is to operate solar power assets to provide commercial, industrial and government customers with renewable energy. For more information, visit the company’s website at ww.vivopower.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information,…

ThursdayDec 07, 2017 2:30 pm

Propanc Biopharma, Inc. (PPCB) Starts Presentation at LD Micro Main Event

Propanc Biopharma (OTC: PPCB) is a clinical stage biopharmaceutical company developing new cancer treatments initially for patients suffering from pancreatic, ovarian and colorectal cancers. Propanc has developed a formulation of anti-cancer compounds, which exert a number of effects designed to control or prevent tumors from recurring and spreading throughout the body. Propanc’s products involve or employ pancreatic proenzymes, which are inactive precursors of enzymes. In the near term, the company intends to target patients with limited remaining therapeutic options for the treatment of solid tumors. In future, it intends to develop products to treat early stage cancer, pre-cancerous diseases and…

ThursdayDec 07, 2017 2:00 pm

Cinedigm Corp. (NASDAQ: CIDM) Starts Presentation at LD Micro Main Event

Cinedigm (NASDAQ: CIDM) powers custom content solutions to the world's largest retail, media and technology companies. Cinedigm provides premium feature films and series to digital platforms including iTunes, Netflix, and Amazon, cable and satellite providers including Comcast, Dish Network and DirecTV, and major retailers including Walmart and Target. Leveraging Cinedigm's unique capabilities, content and technology, the company has emerged as a leader in the fast-growing over-the-top channel business, with four channels under management that reach hundreds of millions of devices while also providing premium content and service expertise to the entire OTT ecosystem. For more information, visit the company’s website…

ThursdayDec 07, 2017 2:00 pm

The Crypto Company (CRCW) Starts Presentation at LD Micro Main Event

The Crypto Company (OTC: CRCW) one of the first publicly traded technology companies in the digital currencies and blockchain sector, offers a portfolio of digital assets, technologies, and consulting services to the blockchain and cryptocurrency markets. Shareholders in The Crypto Company gain diversified exposure to this exponentially growing asset class. For more information, visit the company’s website at www.thecryptocompany.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5)…

ThursdayDec 07, 2017 2:00 pm

Differential Brands Group, Inc. (NASDAQ: DFBG) Starts Presentation at LD Micro Main Event

Differential Brands Group (NASDAQ: DFBG) is a platform that focuses on branded operating companies in the premium apparel, footwear and accessories sectors. Company focus is on organically growing in-house brands through a global, omni-channel distribution strategy while continuing to seek opportunities to acquire accretive, complementary, premium brands. Current brands include Hudson®, a designer and marketer of premium, branded denim and apparel, Robert Graham®, an eclectic apparel and accessories brand, and SWIMS®, a Scandinavian lifestyle brand best known for its water-friendly footwear, apparel and accessories. For more information, visit the company’s website at www.differentialbrandsgroup.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information…

ThursdayDec 07, 2017 1:30 pm

Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) Starts Presentation at LD Micro Main Event

Ritter Pharmaceuticals (NASDAQ: RTTR) develops novel therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases. Its lead product, RP-G28, has the potential to become the first FDA-approved treatment for lactose intolerance, a condition that affects millions worldwide. The Company is further exploring the functionality and discovering the therapeutic potential gut microbiome changes may have on treating/preventing a variety of conditions including: gastrointestinal diseases, immuno-oncology, metabolic, and liver disease. For more information, visit the company’s website at www.RitterPharma.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks…

ThursdayDec 07, 2017 1:30 pm

Biomerica, Inc. (NASDAQ: BMRA) Starts Presentation at LD Micro Main Event

Biomerica (NASDAQ: BMRA) is a global biomedical company that develops, manufactures and markets advanced diagnostic products used at the point-of-care and in hospital/clinical laboratories for the early detection of medical conditions and diseases. Biomerica primarily focuses on products for gastrointestinal disease, diabetes and esoteric testing. The Biomerica InFoods IBS product identifies patient specific foods that when removed may alleviate an individual's IBS symptoms. This patent-pending, diagnostic-guided therapy is designed to allow for a patient-specific, guided dietary regimen to improve Irritable Bowel Syndrome (IBS) outcomes. For more information, visit the company’s website at www.biomerica.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information…

ThursdayDec 07, 2017 1:30 pm

Caladrius Biosciences, Inc. (NASDAQ: CLBS) Starts Presentation at LD Micro Main Event

Caladrius Biosciences (NASDAQ: CLBS) is a clinical stage development company with cell therapy products in development based on multiple technology platforms and targeting autoimmune and select cardiovascular indications. The company is investigating its lead product candidate, CLBS03, an ex vivo expanded polyclonal T regulatory cell therapy for the treatment of recent-onset type 1 diabetes, in a currently enrolling Phase 2 trial. For more information, visit the company’s website at www.caladrius.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release…

ThursdayDec 07, 2017 1:30 pm

US Nuclear Corp. (UCLE) Starts Presentation at LD Micro Main Event

US Nuclear (OTC: UCLE) is principally engaged through its subsidiaries, operating two leading nuclear radiation detection companies, Overhoff Technology Corp. and Optron Scientific Company Inc. The company designs, manufactures and markets branded, full line radiation detection and specialized advanced tritium technology for the nuclear energy industry and for emerging technological processes such as Thorium and Molten Salt (MSR) reactor technologies both domestically and internationally to customers such as United States Government Agencies, the U.S. Military, Homeland Security, Scientific Laboratories, Universities, Hospitals, nuclear reactor facilities in the United States, China, Canada, South Korea, Argentina, Russia and others. For more information, visit…

ThursdayDec 07, 2017 1:00 pm

Ampio Pharmaceuticals, Inc. (NYSE: AMPE) Starts Presentation at LD Micro Main Event

Ampio Pharmaceuticals (NYSE MKT: AMPE) is a development stage biopharmaceutical company primarily focused on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. The company is developing compounds that decrease inflammation by (i) inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and the transcription level; (ii) activating specific phosphatase or depletion of the available phosphate needed for the inflammation process; and (iii) decreasing vascular permeability. For more information, visit the company’s website at http://ampiopharma.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Month: December 2017

VivoPower International PLC (NASDAQ: VVPR) Starts Presentation at LD Micro Main Event

Propanc Biopharma, Inc. (PPCB) Starts Presentation at LD Micro Main Event

Cinedigm Corp. (NASDAQ: CIDM) Starts Presentation at LD Micro Main Event

The Crypto Company (CRCW) Starts Presentation at LD Micro Main Event

Differential Brands Group, Inc. (NASDAQ: DFBG) Starts Presentation at LD Micro Main Event

Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) Starts Presentation at LD Micro Main Event

Biomerica, Inc. (NASDAQ: BMRA) Starts Presentation at LD Micro Main Event

Caladrius Biosciences, Inc. (NASDAQ: CLBS) Starts Presentation at LD Micro Main Event

US Nuclear Corp. (UCLE) Starts Presentation at LD Micro Main Event

Ampio Pharmaceuticals, Inc. (NYSE: AMPE) Starts Presentation at LD Micro Main Event

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsWire Currently Accepts

Company Search

Site Search